Stocks Health care SCNX

NASDAQ · Health care

Scienture Holdings, Inc. (SCNX)

It posted a net loss of $38M. At June 30, 2026 it held $8.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch SCNX in 60 seconds

Follow SCNX

Free, no password. An email when SCNX files with the SEC.

Key facts about Scienture Holdings, Inc.

Net worth

Scienture Holdings, Inc. has a market value (market cap) of $124.8M at the latest share price, and shareholders' equity of $64.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

In fiscal 2025 revenue was $431.6K (+215.9% year on year), with a net loss of $41.5M.

Cash flow

In fiscal 2025 operations used $13.4M of cash.

Latest report

The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR

What Scienture Holdings, Inc. does

Scienture Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SCNX.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where SCNX ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

It paid out $14.9M in cash dividends, 164% of its net income.

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Scienture Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 18, 2026
   Proxy statement DEF 14A
2. September 14, 2026
   Investor disclosure 8-K
3. September 8, 2026
   Preliminary proxy statement PRE 14A
4. August 20, 2026
   Quarterly results 8-K
5. August 13, 2026
   Quarterly report 10-Q · period to June 30, 2026Revenue was $343.6K; diluted EPS -$0.07 versus -$0.48.
6. May 29, 2026
   Executive or director change 8-K
7. May 22, 2026
   Quarterly results 8-K
8. May 15, 2026
   Quarterly report 10-Q · period to March 31, 2026Revenue rose 449% to $56.3K versus the same quarter last year; diluted EPS -$0.08 versus -$0.33.
9. May 5, 2026
   Investor disclosure 8-K
10. May 1, 2026
    Material agreement 8-K

Recent insider filings (Forms 3, 4 and 144): 7, the latest on August 31, 2026. Insider transactions on SEC

Insider trades

What the people running Scienture Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SCNX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Latest filings below 5%: L1 Capital Global Opportunities Master Fund, Ltd. 0% (November 14, 2025); Scoggin International Fund Ltd. 0.01% (August 20, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 6,835,898 shares in total, about $20.8M at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SCNX

What does Scienture Holdings, Inc. do?

Scienture Holdings, Inc. is a company in the Health care sector, listed on NASDAQ as SCNX. Its shares trade on NASDAQ under the ticker SCNX.

What is Scienture Holdings, Inc.'s net worth?

Scienture Holdings, Inc. has a market value (market cap) of $124.8M at the latest share price, and shareholders' equity of $64.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Scienture Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $38M.

When did Scienture Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the proxy statement from September 18, 2026.

Similar companies

Compare SCNX with

Compare SCNX with any company

Follow SCNX

Get an email when Scienture Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SCNX

Free, no password. An email when SCNX files with the SEC.

Where the numbers come from

Financial figures are the values Scienture Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.